Holly A. Shill

Best Publications

• The Parkinson Progression Marker Initiative (PPMI)

  Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf

  1881
  Citations

• Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

  Thomas G. Beach;Charles H. Adler;Lucia I. Sue;Linda Vedders

  972
  Citations

• Unified Staging System for Lewy Body Disorders: Correlation with Nigrostriatal Degeneration, Cognitive Impairment and Motor Dysfunction

  Thomas G. Beach;Charles H. Adler;LihFen F. Lue;Lucia I. Sue

  726
  Citations

• Defining mild cognitive impairment in Parkinson's disease.

  John Nathaniel Caviness;Erika M Driver-Dunckley;Donald J. Connor;Marwan N. Sabbagh

  571
  Citations

• Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study

  Charles H. Adler;Thomas G. Beach;Joseph G. Hentz;Holly A. Shill

  545
  Citations

• Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program

  Thomas G. Beach;Charles H. Adler;Lucia I. Sue;Geidy Serrano

  477
  Citations

• Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology

  Kasandra Burgos;Ivana Malenica;Raghu Metpally;Amanda Courtright

  430
  Citations

• The Montreal Cognitive Assessment and the Mini-Mental State Examination as Screening Instruments for Cognitive Impairment: Item Analyses and Threshold Scores

  Anne M. Damian;Sandra A. Jacobson;Joseph G. Hentz;Christine M. Belden

  310
  Citations

• Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders

  Thomas G. Beach;Charles L. White;Christa L. Hladik;Marwan N. Sabbagh

  302
  Citations

• Quantitative EEG as a predictive biomarker for Parkinson disease dementia

  B. T. Klassen;J. G. Hentz;H. A. Shill;Erika M Driver-Dunckley

  263
  Citations

• Pathologic findings in prospectively ascertained essential tremor subjects

  H. A. Shill;C. H. Adler;M. N. Sabbagh;D. J. Connor

  257
  Citations

• Parkinson disease with dementia: comparing patients with and without Alzheimer pathology.

  Marwan N. Sabbagh;Charles H. Adler;Tyson J. Lahti;Donald J. Connor

  257
  Citations

• Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.

  Douglas G. Walker;Lih-Fen Lue;Charles H. Adler;Holly A. Shill

  194
  Citations

• Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.

  Mei Sun;Jeanne C. Latourelle;G. Frederick Wooten;Mark F. Lew

  179
  Citations

• Concomitant pathologies among a spectrum of parkinsonian disorders.

  Brittany N. Dugger;Charles H. Adler;Holly A. Shill;John Caviness

  174
  Citations

• Gluten sensitivity in sporadic and hereditary cerebellar ataxia.

  Khalafalla O. Bushara;Stephan U. Goebel;Holly Shill;Lev G. Goldfarb

  170
  Citations

• REM sleep behavior disorder and neuropathology in Parkinson's disease

  Ronald B. Postuma;Charles Howard Adler;Brittany N. Dugger;Joseph G. Hentz

  167
  Citations

• Altered pharyngeal muscles in Parkinson disease.

  Liancai Mu;Stanislaw Sobotka;Stanislaw Sobotka;Jingming Chen;Hungxi Su

  164
  Citations

• Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease

  John Nathaniel Caviness;J. G. Hentz;V. G. Evidente;Erika M Driver-Dunckley

  163
  Citations

• Parkinson Disease Affects Peripheral Sensory Nerves in the Pharynx

  Liancai Mu;Stanislaw Sobotka;Stanislaw Sobotka;Jingming Chen;Hungxi Su

  163
  Citations